GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
Clinical trial NCT05215665 · UNKNOWN
Trial details
- NCT number
- NCT05215665
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-15
- Primary completion
- 2024-05-15
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.